Accessing Patients Is the Bottleneck: How to Improve Patient ID and Retention in Chronic Disease Trials

Patient enrollment continues to be one of the biggest risks to timelines in chronic disease trials. Competition for patients and sites poses a major hurdle for sponsors. Many studies struggle to find qualified patients, reach diverse populations, and maintain engagement long enough to generate meaningful outcomes. Traditional recruitment channels can't keep up. Leveraging primary care for chronic disease studies can:

• Accelerate patient identification
• Access underrepresented populations
• Improve retention rates
• Aid in understanding real-world implications of therapies

Join our experts as they explore the opportunities presented by utilizing PCPs in chronic disease research – including accelerating patient identification, accessing underrepresented patient populations, retaining patients in long-term trials, and better understanding how potential treatments work in a real-world setting.